logo

For the Inventor, By the Inventor

Valencia, Spain

Francisco Revert-Ros

This inventor holds 8 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: University of Valencia, Fibrostatin Sociedad Limitada, Fibrostatin, S.l.. Active years: 2006-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francisco Revert-Ros. Retrieved from https://idiyas.com/inventor/francisco-revert-ros

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 37.5

 

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Valcencia, ES (2008)
  • Valencia, ES (2006 - 2020)

Company Filing History:

goldMedal3 out of 52 
 
University of Valencia
 patents
silverMedal1 out of 2 
 
Fibrostatin Sociedad Limitada
 patents
bronzeMedal1 out of 1 
 
Fibrostatin, S.l.
 patent
4. 1 out of 1 
 
Fibrostein, S.l.
 patent
5. 3 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2006-2020

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 10633455 - Method for treating and diagnosing disease using inhibitors of goodpasture antigen binding protein (2020-04-28),
2. 10544083 - GPBP inhibition using Qpeptidomimetics (2020-01-28),
3. 9199936 - GPBP inhibition using Q2 peptidomimetics (2015-12-01),
4. 9066938 - GPBP-1 inhibition and its therapeutic use (2015-06-30),
5. 8586776 - [object Object] (2013-11-19),
6. 7601349 - GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein (2009-10-13),
7. 7326768 - Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders (2008-02-05),
8. 7147855 - GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein (2006-12-12),

Title: Francisco Revert-Ros: Innovator in Medical Therapeutics

Introduction

Francisco Revert-Ros is a prominent inventor based in Valencia, Spain. He has made significant contributions to the field of medical therapeutics, particularly in the diagnosis and treatment of various diseases. With a total of 8 patents to his name, his work has the potential to impact many lives.

Latest Patents

Among his latest patents is a method for treating and diagnosing diseases using inhibitors of Goodpasture antigen binding protein. This invention provides methods for the diagnosis and/or treatment of chronic kidney disease, immune complex-mediated glomerulonephritis, rheumatoid arthritis, and pulmonary fibrosis. Another notable patent involves GPBP inhibition using Q-peptidomimetics, which discloses compounds that inhibit GPBP activity. These compounds are useful as therapeutics in antibody-mediated disorders, drug-resistant cancer, inflammation, protein misfolding, ER stress-mediated disorders, and aberrant apoptosis.

Career Highlights

Throughout his career, Francisco has worked with various companies, including Fibrostein, S.L. His innovative approaches and dedication to research have positioned him as a key figure in the medical field.

Collaborations

Francisco has collaborated with notable individuals such as Juan Saus and Fernando Revert. Their combined expertise has contributed to the advancement of his research and inventions.

Conclusion

Francisco Revert-Ros is a distinguished inventor whose work in medical therapeutics continues to pave the way for new treatment options. His patents reflect a commitment to improving healthcare and addressing complex medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…